Citrullinated amyloid-β (1-42) peptide (human) contains citrulline-modified residues that alter charge distribution and folding dynamics. These changes influence aggregation behavior and molecular interactions. The sequence is used to study structural consequences of post-translational modification. Researchers examine it to map peptide–protein interaction patterns.
CAT No: A13396
Synonyms/Alias:Citrullinated Aβ (1-42); Citrullinated Aβ42; R5C1-42
1. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
4. Myotropic activity of allatostatins in tenebrionid beetles
5. TMEM16F and dynamins control expansive plasma membrane reservoirs
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.